InterVenn Revenue and Competitors
Estimated Revenue & Valuation
- InterVenn's estimated annual revenue is currently $41.1M per year.
- InterVenn's estimated revenue per employee is $193,750
- InterVenn's total funding is $278.1M.
Employee Data
- InterVenn has 212 Employees.
- InterVenn grew their employee count by -8% last year.
InterVenn's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP Quality Assurance and Clinical Lab Affairs | Reveal Email/Phone |
2 | SVP, Clinical Operations & Patient Affairs | Reveal Email/Phone |
3 | Chief Data Officer | Reveal Email/Phone |
4 | Senior Director, Clinical Operations | Reveal Email/Phone |
5 | Senior Manager, Biomarker Validation | Reveal Email/Phone |
6 | General Manager - Philippines | Reveal Email/Phone |
7 | Scientist | Reveal Email/Phone |
8 | Lead Clinical Data Scientist | Reveal Email/Phone |
InterVenn Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is InterVenn?
InterVenn combines next generation epiproteomics, instrumentation and deep learning to augment cancer diagnosis, biomarker and target discovery.
keywords:N/A
$278.1M
Total Funding
212
Number of Employees
$41.1M
Revenue (est)
-8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
InterVenn News
InterVenn is a clinical technology company leveraging AI-powered software to unlock the value of glycoproteomics for the development of...
InterVenn is pioneering a new AI-powered platform to decode and unlock the potential of the glycoproteome for the first time in history.
InterVenn Biosciences today raised $34 million to further develop its platform for precision medicine. The New York-based startup says the funds will be used to accelerate its go-to-market, expansion, and ongoing product R&D efforts. Mass spectrometry, a technique that measures the mass-to-char ...
InterVenn BioSciences, a Redwood City, Calif.-based life sciences and technology company developing an AI-driven mass spectrometry platform, raised $9.4m in funding. The round was led by biotech investor Genoa Ventures, with participation from True Ventures, Amplify Partners, Boost VC, and Prad ...
Other Companies in South San Francisco
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $23.4M | 217 | 11% | $319.7M |
#2 | $35.5M | 229 | -6% | N/A |
#3 | $45.3M | 234 | -8% | $92.1M |
#4 | $35.8M | 238 | -22% | $35M |
#5 | $179.9M | 240 | -60% | $532.5M |